柠檬来源的胞外囊泡在卵巢癌细胞耐药治疗中的应用

王鑫宇; 李新

doi:10.14188/j.1671-8852.2025.0074

您当前的位置：

首页 >

文章列表页 >

柠檬来源的胞外囊泡在卵巢癌细胞耐药治疗中的应用

肿瘤学研究 | 更新时间：2026-11-05

- 柠檬来源的胞外囊泡在卵巢癌细胞耐药治疗中的应用
- Application of lemon⁃derived extracellular vesicles in overcoming chemoresistance in ovarian cancer cells
- 武汉大学学报（医学版） 2025年46卷第9期页码：1130-1136
- 作者机构：
  
  武汉大学人民医院妇科湖北武汉 430060
- 作者简介：
  
  王鑫宇，男，1998—，医学硕士生，主要从事妇科肿瘤的研究，E⁃mail: 2362654538@qq.com
  李新，女，1975—，副教授，主任医师，博士生导师，主要从事妇科疾病的诊治和妇科肿瘤的早期诊断及精准靶向、微创治疗研究，E⁃mail: xin.li@whu.edu.cn
- 基金信息：
  
  国家自然科学基金资助项目(62172302)
- DOI：10.14188/j.1671-8852.2025.0074
  中图分类号： R711
- 收稿：2025-01-23，
  
  纸质出版：2025-09-26
- 稿件说明：
移动端阅览
王鑫宇,李新.柠檬来源的胞外囊泡在卵巢癌细胞耐药治疗中的应用[J].武汉大学学报（医学版）,2025,46(09):1130-1136.

WANG Xinyu,LI Xin.Application of lemon⁃derived extracellular vesicles in overcoming chemoresistance in ovarian cancer cells[J].Medical Journal of Wuhan University,2025,46(09):1130-1136.
王鑫宇,李新.柠檬来源的胞外囊泡在卵巢癌细胞耐药治疗中的应用[J].武汉大学学报（医学版）,2025,46(09):1130-1136. DOI： 10.14188/j.1671-8852.2025.0074.

WANG Xinyu,LI Xin.Application of lemon⁃derived extracellular vesicles in overcoming chemoresistance in ovarian cancer cells[J].Medical Journal of Wuhan University,2025,46(09):1130-1136. DOI： 10.14188/j.1671-8852.2025.0074.

摘要

目的

探究柠檬来源的胞外囊泡（LDEVs）对卵巢癌顺铂耐药细胞株的作用机制，以及对巨噬细胞极化的影响，为卵巢癌的药物治疗提供思路。

方法

提取并纯化LDEVs，使用透射电镜及纳米示踪技术对其进行表征；分别以不同浓度将其加入正常卵巢上皮细胞（IOSE⁃80）、卵巢癌细胞（A2780）和卵巢癌顺铂耐药细胞（A2780/DDP）中孵育不同时间段检测细胞活力；检测LDEVs在顺铂耐药株（A2780/DDP）中与不同浓度顺铂合用的效果；流式细胞术检测与顺铂合用后耐药株的凋亡水平；Western Blot检测对药物外排相关蛋白小窝蛋白⁃1（CAV⁃1）的影响；流式细胞术检测巨噬细胞极化水平。

结果

提取的LDEVs呈典型的双层膜结构、粒径集中在100~200 nm；LDEVs对A2780、A2780/DDP、IOSE⁃80三种细胞的抑制效果均呈浓度及时间依赖性；LDEVs与顺铂合用能加强对耐药株的抑制效果及凋亡水平；LDEVs能下调CAV⁃1的表达；LDEVs能促进巨噬细胞的极化。

结论

LDEVs通过下调CAV⁃1的表达，增强对耐药细胞株的抑制作用并提高细胞凋亡水平，同时促进巨噬细胞极化，从而在抗肿瘤免疫调控中发挥潜在协同作用。

Abstract

Objective

To investigate the mechanism of lemon⁃derived extracellular vesicles (LDEVs) in cisplatin（DDP）⁃resistant ovarian cancer cell lines and their impact on macrophage polarization

providing potential insights for drug therapy in ovarian cancer.

Methods

LDEVs were extracted and purified

and characterized by transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). LDEVs were incubated with normal ovarian epithelial cells（IOSE⁃80）

ovarian cancer cells（A2780）

and drug⁃resistant ovarian cancer cells（A2780/DDP） at various concentrations for different time points to assess cell viability. The effect of LDEVs in combination with different concentrations of DDP on the DDP⁃resistant cell lines was evaluated. Flow cytometry was used to determine apoptosis levels in drug⁃resistant cells after combination treatment with DDP. Western blot analysis was performed to assess the influence of LDEVs on drug efflux protein Caveolin⁃1（CAV⁃1）. Flow cytometry was also used to analyze macrophage polarization.

Results

The extracted LDEVs exhibited a typical bilayer membrane structure with particle sizes concentrated between 100 and 200 nm. LDEVs showed a concentration⁃ and time⁃dependent inhibitory effect on A2780

A2780/DDP

and IOSE⁃80 cell lines. The combination of LDEVs and DDP enhanced the inhibitory effect and apoptosis levels in the drug⁃resistant cell lines. LDEVs downregulated CAV⁃1 expression. Additionally

LDEVs promoted macrophage polarization.

Conclusion

LDEVs enhance the inhibition and apoptosis of drug⁃resistant cell lines by downregulating the expression of CAV⁃1

while also promoting macrophage polarization.

关键词

Keywords

references

KUROKI L , GUNTUPALLI S R . Treatment of epithelial ovarian cancer [J ] . BMJ , 2020 , 371 : m3773 .

DEMPKE W C M , ZIELINSKI R , WINKLER C , et al . Anthracycline‑induced cardiotoxicity: Are we about to clear this hurdle? [J ] . Eur J Cancer , 2023 , 185 : 94 ‑ 104 .

FAN J Y , TO K K W , CHEN Z S , et al . ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance [J ] . Drug Resist Updat , 2023 , 66 : 100905 .

CHENG L , HILL A F . Therapeutically harnessing extracellular vesicles [J ] . Nat Rev Drug Discov , 2022 , 21 ( 5 ): 379 ‑ 399 .

LIAN M Q , CHNG W H , LIANG J , et al . Plant‑derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications [J ] . J Extracell Vesicles , 2022 , 11 ( 12 ): e12283 .

XU Z J , XU Y Z , ZHANG K , et al . Plant‑derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities [J ] . J Nanobiotechnology , 2023 , 21 ( 1 ): 114 .

HSU C L , PEI W , CHEN T C , et al . Optimized sugar‑free citrus lemon juice fermentation efficiency and the lipid‑lowering effects of the fermented juice [J ] . Nutrients , 2023 , 15 ( 24 ): 5089 .

NING R D , CHEN G , FANG R , et al . Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c‑Myc signaling pathway in human osteosarcoma cells [J ] . Biol Res , 2021 , 54 ( 1 ): 40 .

RI M H , LI M Y , XING Y , et al . Narirutin exerts anti‑inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages [J ] . Phytother Res , 2023 , 37 ( 4 ): 1293 ‑ 1308 .

HUANG Y F , WANG S M , CAI Q , et al . Effective methods for isolation and purification of extracellular vesicles from plants [J ] . J Integr Plant Biol , 2021 , 63 ( 12 ): 2020 ‑ 2030 .

MA S B , SUN B F , DUAN S Q , et al . YTHDF2 orchestrates tumor‑associated macrophage reprogramming and controls antitumor immunity through CD8 + T cells [J ] . Nat Immunol , 2023 , 24 ( 2 ): 255 ‑ 266 .

KIM J , LI S Y , ZHANG S Y , et al . Plant‑derived exosome‑like nanoparticles and their therapeutic activities [J ] . Asian J Pharm Sci , 2022 , 17 ( 1 ): 53 ‑ 69 .

RONG X , XU J , JIANG Y , et al . Citrus peel f lavonoid nobiletin alleviates lipopolysaccharide‑induced inflammation by activating IL‑6/STAT3/FOXO3a‑mediated autophagy [J ] . Food Funct , 2021 , 12 ( 3 ): 1305 ‑ 1317 .

YANG M , LIU X Y , LUO Q Q , et al . An efficient method to isolate lemon derived extracellular vesicles for gastric cancer therapy [J ] . J Nanobiotechnology , 2020 , 18 ( 1 ): 100 .

LIN F K , LI X D , WANG X J , et al . Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer [J ] . J Exp Clin Cancer Res , 2022 , 41 ( 1 ): 129 .

DUDÃU M , CODRICI E , TANASE C , et al . Caveolae as potential hijackable gates in cell communication [J ] . Front Cell Dev Biol , 2020 , 8 : 581732 .

PARTON R G , SIMONS K . The multiple faces of caveolae [J ] . Nat Rev Mol Cell Biol , 2007 , 8 ( 3 ): 185 ‑ 194 .

YANG C Y , HE B , DAI W B , et al . The role of caveolin‑1 in the biofate and efficacy of anti‑tumor drugs and their nano‑drug delivery systems [J ] . Acta Pharm Sin B , 2021 , 11 ( 4 ): 961 ‑ 977 .

XIAO Q , ZHAO W , WU C T , et al . Lemon‑derived extracellular vesicles nanodrugs enable to efficiently overcome cancer multidrug resistance by endocytosis‑triggered energy dissipation and energy production reduction [J ] . Adv Sci , 2022 , 9 ( 20 ): e2105274 .

LI M Y , YANG Y H , XIONG L T , et al . Metabolism, metabolites, and macrophages in cancer [J ] . J Hematol Oncol , 2023 , 16 ( 1 ): 80 .

GOPINATH V K , MOHAMMAD M G , SHEELA S . Immunomodulatory effect of IL‑1RA in LPS‑activated macrophage/dental pulp stem cells co‑culture [J ] . Int Endod J , 2023 , 56 ( 1 ): 27 ‑ 38 .

LAZAR M , SANDULESCU M , BARBU E C , et al . The role of cytokines and molecular pathways in lung fibrosis following SARS‑CoV‑2 infection: A physiopathologic (Re)view [J ] . Biomedicines , 2024 , 12 ( 3 ): 639 .

SUPURAMANIAN S S , DSA S , HARIHAR S . Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer [J ] . Explor Target Antitumor Ther , 2023 , 4 ( 5 ): 912 ‑ 932 .

XIA Y Q , RAO L , YAO H M , et al . Engineering macrophages for cancer immunotherapy and drug delivery [J ] . Adv Mater , 2020 , 32 ( 40 ): e2002054 .

CHEN S Z , SAEED A F U H , LIU Q , et al . Macrophages in immunoregulation and therapeutics [J ] . Signal Transduct Target Ther , 2023 , 8 ( 1 ): 207 .

LIU X M , WANG M K , JIANG Y C , et al . Magnetic resonance imaging nanoprobe quantifies nitric oxide for evaluating M1/M2 macrophage polarization and prognosis of cancer treatments [J ] . ACS Nano , 2023 , 17 ( 24 ): 2 4854‑ 24866 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

香菇多糖体外逆转A2780卵巢癌细胞顺铂耐药及可能机制

干扰素调节因子与动脉粥样硬化的研究进展

恶病质指数对手术治疗的上皮性卵巢癌患者预后的评估价值

卵巢癌分子亚型及关键基因的识别和预后风险模型的构建及评价

肠道真菌群与消化系统肿瘤关系的研究进展